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Abstract: 
Histone modifications are important epigenetic marks that influence chromatin structure and 
consequently play a role in the control of eukaryotic transcription. Several histone modifying 
enzymes have been characterized in Schistosoma mansoni and it has been suggested that the 
regulation of gene transcription in schistosomes may require the action of these enzymes. 
However, the influence of chromatin structure on gene transcription in schistosomes has never 
been investigated. Chromatin immunoprecipitation (ChIP) is the technique of choice to study 
the relationship between histone modifications and gene expression. Although this technique 
has been widely used with cultured cells from model organisms and with many unicellular 
organisms, it remains challenging to apply this technique to non-conventional organisms that 
undergo complex life-cycles. In this work, we describe a native ChIP procedure that is 
applicable to all the stages of the S. mansoni life cycle and does not require expensive 
equipment. Immunoprecipitated DNA was analysed on a whole-genome scale using 
massively parallel sequencing (ChIP-Sequencing or ChIP-Seq). We show that ChIP-Seq and 
conventional quantitative PCR deliver comparable results for a life-cycle regulated locus, 
smRHO, that encodes a guanine-protein coupled receptor. This is the first time that the ChIP-
Seq procedure has been applied to a parasite. This technique opens new ways for analyzing 
epigenetic mechanisms in S. mansoni at a whole-genome scale and on the level of individual 
loci. 
 
Introduction 
In eukaryotes, genotype and epigenotypes manifest themselves as a complex nuclear structure 
called chromatin. This nucleoprotein structure contains histone and non-histone proteins that 
interact with the genomic DNA. Chromatin exists either as a relaxed structure that is 
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permissive to gene expression and called euchromatin, or as a condensed structure that is 
typically silent and called heterochromatin [1]. The genotype refers to the DNA sequence of 
an organism. “Epigenotype” refers to the sum of chemical modifications of DNA (e.g., DNA 
methylation) and of DNA-associated proteins (e.g., histones) that can affect chromatin 
structure. Other mediators of epigenetic information are non-coding RNA and the location of 
genes in the nucleus [2, 3]. Posttranslational modifications of histones, for example 
methylation, acetylation and phosphorylation, are widely studied and have been shown to play 
a key role in chromatin compaction and control of gene transcription [4].  
Schistosoma mansoni is a parasitic helminth whose life-cycle is characterized by passage 
through two obligatory sequential hosts: the fresh-water snail Biomphalaria glabrata (or 
dependent on the geographical location other Biomphalaria species) for the asexual stages, 
and human or rodents as hosts for the sexual stages. An estimated 200 million people in 74 
countries suffer from schistosomiasis caused by S. haematobium, S. japonicum, and S. 
mansoni, and schistosomiasis is the most severe tropical disease in terms of morbidity after 
malaria [5]. Eggs of the parasite accumulate in the host’s liver and cause disease symptoms. 
Eggs are also released with the faeces and when they come into contact with water, free-
swimming miracidia hatch and actively seek B. glabrata snails as intermediate host. After 
penetration into this host, the parasite develops via a primary “mother” sporocyst and a 
secondary “daughter” sporocyst generation into cercariae that can infect the vertebrate host.  
It has been proposed that the regulation of gene transcription in schistosomes may require the 
action of factors that can modify chromatin [6]. Genomic DNA of S. mansoni is not 
methylated [7]. However, histone-modifying proteins are present. The histone arginine 
methyltransferase, SmPRMT1, for instance plays a role in nuclear receptor-mediated 
chromatin modification [8]. A predicted histone acetyltransferase, SmGCN5, displays high 
acetyltransferase activity with histone H3 as a substrate [9], SmCBP1 acetylates histones with 
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a marked activity toward H4 [10] and several histone deacetyalses (HDACs) have been 
characterized in schistosomes [11]. Transformation of miracidia into sporocysts can be 
blocked by HDAC inhibitors [12]. Posttranscriptional gene silencing (PTGS) can occur, both 
in miracidia and in adult stages of this parasite [13] [14]. PTGS shares pathway components 
with RNA-mediated heterochromatin formation identified in fission yeast and plants [15]. 
Taken together, these results suggest that the chromatin of S. mansoni may be 
compartmentalized as that of other eukaryotes and that the different levels of compaction may 
be developmentally regulated. It is therefore obvious that chromatin structure changes must be 
analyzed in S. mansoni and other metazoan parasites.  
One of the methods to map chromatin along the genome is chromatin immunoprecipitation 
(ChIP). When we attempted to apply existing protocols to S. mansoni we realized that they 
were not adapted to the model, and we have therefore developed a native chromatin 
immunoprecipitation procedure (N-ChIP) for S. mansoni based on existing protocols [16]. S. 
mansoni undergoes a complex life cycle with larval stages for which biological samples are 
not readily available in sufficient amounts for many laboratory uses. Exhaustive optimization 
was thus required to apply the ChIP procedure to this organism. We describe here an 
optimized N-ChIP procedure for S. mansoni. This includes cell lysis, extraction of nuclei, 
chromatin fragmentation, choice of antibodies, and conditions for antibody/chromatin 
interactions. We optimized the sensitivity of the assay to reduce the amount of starting 
material and render the procedure feasible to all the life cycle stages of this parasite. In 
addition, immunoprecipitated DNA was analyzed at the whole-genome scale by high-
throughput sequencing on an Illumina/Solexa 1G sequencing system. Results were validated 
through quantitative PCR analyses at the SmRHO locus, a previously characterized gene that 
encodes a guanine-protein coupled receptor (GPCRs) [17].  
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Methods 
Parasite strains and cell culture: 
A Guadeloupean strain of S. mansoni (GH2) was used in this study. The strain was 
maintained in its sympatric B. glabrata strain, and in hamsters (Mesocricetus auratus) as 
described previously ([18] and [19]). Eggs were axenically recovered from 50-day infected 
hamster livers and miracidia were hatched from eggs as previously described [19]. Miracidia 
were concentrated by sedimentation on ice for 15 min. Subsequently, miracidia were induced 
to transform to sporocysts in-vitro by incubation in sterile filtered B. glabrata embryonic 
(Bge) cell medium (Schneider’s Drosophila Medium (Gibco BRL, #21720-016) with 4.5 % 
(w/v) lactalbumin hydrolysate (Gibco BRL, #18080-028), 10% (v/v) fetal calf serum (Sigma, 
#F-2442), 1.3% (w/v) galactose (Sigma, #G-5388), 1x antibacterial/antimicotic solution 
(Sigma, #A5955), pH 7.4) during 24 hours. Cercariae were recovered from infected snails (4 
weeks post-infection) and harvested on ice by pipetting. They were pelleted by centrifugation 
(4000 g for 6 min). Eight-week adult worms were recovered by portal perfusion of hamsters 
with 0.9 % (w/v) NaCl and 0.8 % (w/v) trisodium citrate. For the ChIP procedure, miracidia, 
sporocysts, cercariae and adults were kept at -80°C. For RNA extractions, miracidia, 
sporocysts, cercariae and adults were pelleted and suspended immediately into 100 µl lysis 
buffer (Dynabeads mRNA DIRECT™ Micro kit, Dynal® Biotech, Invitrogen, #610.21) in 
RNase-free tubes and stored at -80°C. 
Human lymphoblastic cells (CCRF-CEM) were grown as stationary suspension cultures in 
RPMI1640 medium with 2 mM l-glutamine, 10 % (v/v) heat-inactivated fetal calf serum, and 
1x antibiotics (penicillin and streptomycin), at 37 °C in a humidified chamber (5% CO2). 
mRNA Isolation:  
Messenger RNA was extracted from parasites (1000 miracidia, 1000 sporocysts, 1000 
cercariae, 10 adults) using a Dynabeads
®
 mRNA DIRECT Micro kit (Invitrogen, #610.21) 
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according to the manufacturer’s instructions. At the end of the purification procedure, RNA 
was separated from the beads by heating to 80°C for 2 min in 20µl 10mM Tris-HCl, pH 7.5. 
Resuspended mRNA was transferred to fresh RNase-free tubes.  
cDNA Synthesis: 
First strand cDNA was synthesized using 10 µl of the mRNA preparation in a final volume of 
20 µl (0.5 mM dNTPs, 0.01 mM DTT, 1x first-strand buffer, 5 µM oligo-dT, 40 Units RNase 
out) with 200 Units of SuperScript™ II RT (Invitrogen, # 18064-014) as recommended per 
manufacturer instruction. After reverse transcription, the cDNA was purified with the 
Wizard
®
 SV gel and PCR clean-up system (Promega, #A9281). cDNA was eluted from the 
column with the elution buffer of the kit in a final volume of 100 µl.  
Real time PCR analysis:  
Real time PCR analyses were performed using the LightCycler® 2.0 system (Roche Applied 
Science) and LightCycler® Faststart DNA Master SYBR Green I kit (Roche Applied Science, 
12239264001). qPCR amplification was done with 2.5 µl of cDNA in a final volume of 10 µl 
(3 mM MgCl2, 0.5 µM of each primer, 1 µl of master mix). The primers were designed with 
the LightCycler
®
 probe design software or the web-based Primer3 plus interface 
(http://www.bioinformatics.nl/cgi-bin/primer3plus/primer3plus.cgi) (Supplementary Table 1). 
The following Light-Cycler run protocol was used: denaturation, 95°C, 10 min; amplification 
and quantification (repeated 40 times), 95°C for 10 s, 62°C for 5 s, 72°C for 16 s; melting 
curve, 60–95°C with a heating rate of 0.1°C/s and continuous fluorescence measurement, and 
a cooling step to 40°C. For each reaction, the crossing point (Ct) was determined using the 
‘‘Fit Point Method’’ of the LightCycler Software 3.3. PCR reactions were done in duplicates 
and the mean value of the Ct was calculated. The -tubulin gene was used as an internal 
control [20]. The amplification of a unique band was verified by agarose gel electrophoresis 
for each qPCR product. 
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Sequence analysis: 
Alignment of DNA sequences was performed using Sequencher
TM
 software (Gene Codes 
Corporation). 
Western blot:  
Western blots were performed as described previously [12]. 
Native chromatin immunoprecipitation (N-ChIP): 
Biological samples (miracidia, sporocystes, cercariae, adults and lymphoblasts) were 
centrifuged at 4000 rpm for 10 min at 4°C. The pellets were suspended in 1ml of buffer 1 (0.3 
M sucrose, 30 mM KCl, 7.5 mM NaCl, 2.5 mM MgCl2, 0.05 mM EDTA, 0.1 mM PMSF, 0.5 
mM DTT, 7.5 mM Tris-HCl, pH 7.5) containing protease inhibitor cocktail tablets (two 
tablets for 50ml of buffer 1) (Roche Applied Science, #116974998001) and 5 mM sodium 
butyrate as histone deacetylase inhibitor (Sigma, #B5887). Samples were lysed by adding 1 
ml buffer 1 with 0.8% NP40 and homogenized in a SZ22 tissue grinder tube (Kontes Glass 
Company, #885462-0022) using an SC tissue grinder pestle (Kontes Glass Company, 
#885451-0022) on ice for 3 min. The samples were kept on ice for 7 min after which lysates 
were overlaid on 8 ml of buffer 3 (1.2 M sucrose, 30 mM KCl, 7.5 mM NaCl, 2.5 mM MgCl2, 
0.05 mM EDTA, 5 mM sodium butyrate, 0.1 mM PMSF, 0.5 µM DTT, 7.5 mM Tris HCl pH 
7.5) in Corex centrifuge tubes and centrifuged for 20 min (8500 rpm at 4°C) in a JJ-25 
beckman coulter centrifuge using a TA-14-50 rotor. The buffer was removed and the pelleted 
nuclei were suspended in 1ml chromatin digestion buffer (0.12 M sucrose, 0.2 mM PMSF, 4 
mM MgCl2, 5 mM sodium butyrate, 1 mM CaCl2, 0.05 M Tris HCl pH 7.5) and divided into 
aliquots of 500 µl in 1.5 ml Eppendorf tubes. 
Chromatin digestion was performed for 4 min at 37°C with 1µl (15 U) of microccocal 
nuclease (MNase) (USB, #70196Y). To stop the reaction, 20 µl of 0.5M EDTA was added 
and the tubes were immediately placed on ice. Samples were centrifuged for 10 min (13000 
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Xg at 4°C) and the supernatant (Fraction S1) was transferred into fresh tubes. The pellets (P1) 
were suspended in 100 µl dialysis buffer (200 µM EDTA, 200 µM PMSF, 5 mM sodium 
butyrate, 1 mM Tris HCl pH 7.5) and dialyzed overnight at 4°C in a Slide-A-Lyser MINI 
Dialysis Unit (cut-off at 3,500 Daltons) (Pierce, #69550). The fraction that remained in the 
dialysis tubes was centrifuged for 10 min (13000 Xg at 4°C). The supernatant (Fraction S2) 
was transferred into fresh tubes. Fractions S1 and S2 were then centrifuged three times for 10 
min (13000 Xg at 4°C) and each time the supernatants were transferred into fresh tubes. 
Chromatin from two combined fractions S1 and S2 were pooled and quantified by measuring 
the OD at 260nm. Thirty µg of chromatin were used and antibodies were added in excess (≥ 
saturating amount). An appropriate amount of stock solution was added to generate 
immunoprecipitation incubation buffer (150 mM NaCl, 20 mM sodium butyrate, 5 mM 
EDTA, 100 µM PMSF, 20 mM Tris HCl pH 7.5). Samples were incubated overnight at 4°C 
on a rotating wheel. 
Fifty µl of protein A-sepharose (Sigma, #P3391) were added and incubated with the 
chromatin-antibody complexes for 4 hours at 4°C on a rotating wheel. The chromatin-
antibody-protein A bead mixture was centrifuged for 10 min (11660 Xg at 4°C). The 
supernatant was transferred to a fresh tube, yielding the unbound fraction (“UB”). 
Pellets (chromatin-antibody-protein A bead complex) were suspended in 10 ml washing 
buffer (50 mM Tris HCl pH 7.5, 10 mM EDTA, 5 mM sodium butyrate, 75 mM NaCl) and 
mixed gently for 10 min on a rotating wheel at 4°C. The mixture was centrifuged for 10 min 
at 4000 rpm at 4°C. The same procedure was repeated twice with increasing stringency 
conditions by using 125 mM and 175 mM NaCl as wash buffers, respectively. Finally, the 
pellets were suspended in 500 µl elution buffer (1% SDS, 20 mM Tris HCl pH 7.5, 50 mM 
NaCl, 5 mM EDTA, 20 mM sodium butyrate and 100 µM PMSF) and incubated for 15 min at 
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room temperature on a rotating wheel. The mixture was centrifuged for 10 min at 11600 g at 
18°C, and the supernatants with the bound fraction (“B”) was transferred into fresh tubes.   
DNA from the bound and unbound fractions was extracted with phenol/chloroform. DNA 
precipitation was done overnight at -80°C with 0.02 µg/µl glycogen, one volume isopropanol 
after adjusting the NaCl concentration to 250 mM. After centrifugation and a 70% ethanol 
wash, the pellets were suspended in 20 µl 10mM Tris HCl pH 7.5. The amounts of gene-
specific sequences associated with each antibody were quantified by real-time PCR. A 
schematic representation and a detailed step-by-step procedure are described on our webpage: 
http://methdb.univ-perp.fr/cgrunau/methods/native_chip_sm.html . 
Generation of Illumina/Solexa libraries: 
DNA (30 ng) from native ChIP was polished to generate blunt ended fragments, add 3’-dA 
overhangs by treatment with Klenow polymerase and ligated to adapters as described 
(Pomraning et al., 2008). Fragments were size selected (150 bp to 500 bp) after migration 
through a 2% NuSieve agarose gel and sequencing libraries were generated by PCR 
amplification with 1 µl sample DNA, 1 X Phusion polymerase mix (Finnzymes, #F531), 2.25 
µM of each Solexa PCR primer. We used a standard protocol: denaturation, 90°C, 30s; 
amplification (repeated 18 times), 98°C for 10 s, 65°C for 30 s, 72°C for 30 s; final 
elongation, 72°C, 5min. PCR products were purified on QIAquick PCR Purification columns 
(Qiagen, #28104) and eluted in 30 µl Qiagen elution buffer. We quantified the DNA library 
with a Nanodrop1000 spectrophotometer (Thermo Scientific) and clusters were generated 
with 4 pM of the 10 nM library dilution on the Illumina cluster station. A 36-cycle sequencing 
kit on the Illumina 1G analyzer was used according to the manufacturer’s instructions [21].  
Processing 1G data: 
The resulting short reads were initially processed with the standard Illumina pipeline. The 
ELAND software trims all reads to 32 nt to decrease error rates on the Illumina 1G platform. 
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Only reads that matched a unique genomic locus with no (U0), one (U1) or two mismatches 
(U2) to the S. mansoni reference genome sequence 
(http://www.sanger.ac.uk/Projects/S_mansoni/) were considered for further analysis. We used 
“findpeaks” software to generate a lists of peaks and their genomic locations [22].  
The rhodopsin gene (SmRho) was analyzed for enrichment of H3K9Ac by amplification of 
seven regions (amplicons R1 to R8) that were also used for validation by qPCR. We summed 
the U0 and U1 values for each bp in amplicons R1 to R8 (see Supplementary Table 1) and 
divided these sums by the length of each amplicon. For normalization, these values were 
divided by the value for R1 that is located 5.9 kb upstream of the transcriptional start site of 
SmRho. 
Quantitative real-time PCR: 
Real-time PCR was performed as previously described on a two-fold dilution of the N-ChIP 
samples with the primers described in Supplementary Table 1. Primer sets were designed to 
amplify amplicons shorter than 150 bp. Above this size, qPCR sensitivity is strongly affected, 
which results in background and amplification bias. The amount of target DNA recovered in 
the immunoprecipitated fraction was quantified by calculating the percent input recovery (% 
IR) normalized with the percent input recovery obtained with the -tubulin gene. The percent 
input recovery of the bound immunoprecipitated fraction for each amplicon was calculated as 
previously described [23] by the following formula: % input recovery = 100*E^(Ct (input) - 
Ct (IPBound)). The percent background was calculated by the following formula: % 
background = 100*E^(Ct (input) - Ct (C-Bound)), where E is the primer efficiency designed to 
amplify the amplicon, Ct (IPBound) is the Ct of the bound fraction obtained in the 
immunoprecipitated sample, Ct (C-Bound) is the Ct of the bound fraction obtained in the 
negative control (fraction without antibody), and Ct (input) is the Ct of the unbound fraction 
obtained in the negative control. It represents the quantity of chromatin that was used for the 
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study minus the fraction that bound non-specifically to the protein A Sepharose beads. 
 
Results 
Many commercial antibodies do not recognize histones of S. mansoni or bind unspecifically 
to proteins 
We used ChIP-grade antibodies when available. We tested antibodies raised against specific 
modifications of histone H3 or histone H4 from Abcam, Upstate and Active Motif (Table 1). 
These commercially available antibodies are raised against conserved peptides of histone 
proteins. Prior to any ChIP analysis, we performed western blots to confirm that these 
commercial antibodies were suitable for detection of modified histones of S. mansoni. The 
Upstate antibody raised against acetylated H3K9 (Cat# 07-352) resulted in a unique, specific 
band (supplementary figure 1). Other antibodies from Upstate or Active Motif (see Table 1) 
led to the detection of a band at the expected size but detected also several non-specific bands. 
These non-specific bands were not caused by secondary antibody interaction as this control 
alone did not reveal any signals (data not shown). Most Abcam antibodies did not recognize 
any S. mansoni proteins by western blot; an exception was the antibody against the C-
terminus of H3 (Cat# ab1791) (supplementary figure 1). All optimization steps for the ChIP 
procedure were performed with the Upstate antibody raised against acetylated H3K9 
(H3K9Ac).  
The antibody type and amount must be determined experimentally 
Since the western blot analysis with different antibodies did not always lead to unique bands, 
the amount of antibodies required in each N-ChIP reaction was determined by titration. N-
ChIP reactions were performed starting with 1500 sporocysts for one immunoprecipitation 
assay and increasing concentrations of each antibody were used. Immunoprecipitated DNA 
was analyzed by qPCR on the -tubulin gene. The antibody from Upstate that specifically 
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recognized H3K9Ac in western blots was saturating at 4 µl (supplementary figure 1A). In 
commercial antibody preparations, the antibody concentration (g/l) is not always indicated, 
however, the standardized production technology allows for reproducibly results based on 
volume values. The H3K9Me3 antibody from Abcam successfully immunoprecipitated S. 
mansoni chromatin but no signal was obtained with this antibody on western blots 
(supplementary figure 1B). Saturation for this antibody was reached at 4 µg. The antibodies 
from Upstate that recognized H3K9Me3 and H3K27Me1 never reached saturation although 
up to 40 µg of antibody were used for N-ChIP experiments (supplementary figure 1C and D). 
Apparently, these antibodies interact with additional proteins. This is in agreement with the 
western blots where additional high molecular weight bands were revealed. Their non-specific 
interaction may interfere with the immunoprecipitation and lead to background. Examination 
of S. mansoni sequence databases indicates that other proteins with conserved histone-like 
domains exist (data not shown), which may be recognized by these antibodies. Our findings 
show that the affinity of antibodies to S. mansoni histones can vary substantially, even if they 
have been tested on a wide range of model organisms. Thus, quantity and type of antibody for 
N-ChIP must always be determined experimentally. 
Optimization of the N-ChIP procedure for different S. mansoni life cycle stages: 
We established the S. mansoni N-ChIP protocol based on the previously published methods 
[16, 24]. Details of the procedure are described in the method section. We have optimized 
both lysis and extraction of nuclei for S. mansoni larvae (miracidia, sporocysts and cercariae) 
and adults. We found four minutes to be the optimum time for micrococcal digestion; this 
fragmented chromatin into mononucleosomes, thus providing the highest possible resolution 
for ChIP assays.  
We also optimized washing steps and stringency conditions to reduce the background and 
increase signal to background ratio as much as possible. Triple washing, each time 10 min, of 
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fraction S1 and S2, and later of the chromatin-antibody-protein A complex (see Material and 
Methods) are essential.  
To determine the minimum amount of biological material, the procedure was used with 3000, 
1500, 750 and 375 miracidia for one immunoprecipitation with 2 µl antibody against 
H3K9Ac. The immunoprecipitated DNA was analysed by qPCR of a segment within the -
tubulin gene. This experiment indicates that with 3000, 1500 and 750 miracidia, the input 
recovery is 9%, with background levels below 1% (data not shown). Using 375 larvae, the 
background levels increase to 5%. We concluded that at least 750 larvae are necessary to 
successfully perform N-ChIP.  
We quantified the immunoprecipitated DNA applying our N-ChIP procedure with an excess 
of antibody against H3K9Ac (8 µl). Starting with 1500 miracidia, sporocysts and cercariae 
and a single adult, we were able to immunoprecipitate 100 ng, 170 ng, 110 ng and 120 ng of 
DNA, respectively, which allowed us to perform 16 qPCR analyses.  
Alternatively, we applied a carrier N-ChIP procedure using lymphoblast cells as carrier cells. 
This procedure has been previously described to permit ChIP analysis of as few as 100 cells 
[25]. However, despite extensive washes and high stringency conditions, this procedure 
resulted in strong background and was therefore deemed not applicable to S. mansoni cells. 
Profile of H3K9Ac enrichment along the rhodopsin gene 
(I) ChIP-sequencing 
ChIP-sequencing (ChIP-Seq) combines chromatin immunoprecipitation with high-throughput 
parallel sequencing. This method is increasingly being used to map protein–DNA interactions 
in-vivo on a genome scale [26] [27] [28]. Our N-ChIP procedure was applied to miracidia, 
cercariae and adults using 8 µl of the Upstate antibody against H3K9Ac. We then performed 
genome-wide sequencing of the immunoprecipitated DNA on an Illumina/Solexa 1G genome 
analyzer. We generated 23,758, 27,958 and 34,925 clusters for adults, cercariae and miracidia 
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respectively, corresponding to roughly 660 Mb. Although the length of the input DNA is 
approximately 150 bp, only 36 nt are sequenced for each read. Trimmed, 32-nt reads were 
mapped to the S. mansoni reference genome with the Solexa ELAND software and only reads 
that map to unique genomic locations in the reference genome (U0, U1 and U2) were 
considered for further analysis. Regions of high sequencing read density are referred to as 
peaks. We used the findpeaks software [22] to generate a list of peaks that comprises the 
genomic locations of sites inferred to be occupied by H3K9Ac. This data is not yet fully 
analyzed but will be made available in the future. 
To validate our N-ChIP-seq analysis, we examined the profile of H3K9Ac along the S. 
mansoni rhodopsin gene (SmRHO). SmRHO (Smp_104210) encodes a guanine-protein 
coupled receptor (GPCR), a member of an important family of eukaryotic receptor molecules 
that connects intracellular second messengers to extra-cellular inputs [29]. The rhodopsin 
subfamily of GPCRs encodes light-absorbing proteins that mediate dim light vision. SmRHO 
has been previously identified in S. mansoni. This gene shows large life-cycle-specific 
changes in gene expression [17]. We measured transcript levels of the rhodopsin gene at 
different developmental stages by qPCR with the R7 primer set (Figure 1). Rhodopsin is 
strongly expressed in cercariae. Transcript levels in miracidia and sporocysts are four- and 
tenfold lower, respectively. Rhodopsin expression was barely detectable in adults. This 
confirms previous analyses, where rhodopsin expression had been investigated by semi-
quantitative RT-PCR [17].  
The predicted coding region of SmRHO (GenBank accession number AF155134) was used to 
identify Smp_scaff001984 as the scaffold of the current S. mansoni genome assembly 
(assembly 4) that carries the entire SmRHO gene. Alignment of the coding sequence with 
Smp_scaff001984 was used to annotate the gene. SmRHO spans a 30 kb region from position 
20699 to 50125 of Smp_scaff001984 (Figure 2). The gene has seven exons. Exon size varies 
 15 
from 85 bp to 414 bp, and intron size varies from 791 bp to 12,138 bp. We noted some 
discrepancies with the GeneDB S. mansoni annotation (version 4). Exon 1 of the gene is not 
annotated on Smp_scaff001984. Furthermore, a 146 bp sequence corresponding to the 5’ end 
of exon 5 is missing in the assembly of Smp_scaff001984 although a genomic DNA sequence 
that corresponds to this missing part is present in the trace sequence “shisto6493g08.p1k”, 
which suggests incomplete assembly of this scaffold. The transcriptional start site is at 
position 20,699 and the predicted start codon is at position 31,407 of Smp_scaff001984.  
We added the U0 and U1 findpeaks output values that correspond to R1 to R8 locations along 
SmRHO (see Supplementary Table 1). In miracidia, two regions are enriched for H3K9Ac: 
region R2, located 2.2 kb upstream of the transcriptional start site, and R4, located 100 bp 
downstream of the transcriptional start site (Figure 2). In adults, H3K9Ac is underrepresented, 
which is consistent with the lack of expression of SmRHO in this stage (Figure 1). H3K9Ac is 
a histone mark mainly found in the promoters of active genes or within the coding sequence 
of active genes [30].  
(II) ChIP and qPCR 
ChIP-qPCR was performed on miracidia, sporocysts, cercariae and adults to validate the 
ChIP-Seq analysis at the rhodopsin locus (Figure 2 and Supplementary Table 1). The percent 
input recovery was calculated for regions R1 to R8 as described in the Materials and Methods. 
The results were normalized with the percent input recovery of the -tubulin gene. All data 
were normalized to the R1 results. The ChIP-qPCR analysis showed enrichment in H3K9Ac 
at the R2 in cercariae, R3 in sporocysts and R4 in miracidia but no enrichment was observed 
on the ChIP product obtained from adults. These results are consistent with the expression 
analysis and confirm the results obtained on adults, cercariae and miracidia with the ChIP-Seq 
analysis. 
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Discussion: 
Chromatin immunoprecipitation is the technique of choice for studying protein-DNA 
interactions and to investigate the relationships between histone modifications and gene 
expression [4]. Particularly, ChIP in combination with high throughput sequencing analysis is 
of considerable interest to investigate the specific roles of individual histone modifications. 
Generally speaking, these analyses have been restricted to cultures of cells from model 
organisms [31][26][30]. ChIP has also been widely applied to unicellular parasites [32][33] 
[34][35][36] and combined with whole genome analysis using the “ChIP-on-chip” technology 
[37][38]. Metazoan parasites are more difficult to study by these methods, as they go through 
complex life cycles. Caenorhabditis elegans is the only metazoan of a size comparable to S. 
mansoni for which a ChIP protocol was published [39].  
In the present work, we describe for the first time a protocol to perform native chromatin 
immunoprecipitation of S. mansoni. We have optimized all individual steps of this procedure. 
We show the feasibility of the technique for the investigation of all life cycle stages of this 
parasite, at the same time minimizing the amount of biological samples required. A drawback 
of most current ChIP protocols is the requirement for high numbers of cells, which limits the 
feasibility of ChIP for samples with limited amount of starting material, as is the case with S. 
mansoni larvae. Therefore, we established conditions that are as sensitive as possible to 
minimize the amount of biological samples (750 larvae or one adult) required for each 
experiment. We have investigated the quality of histone-specific antibodies from different 
companies and show that each antibody must be tested carefully before it can be used for the 
ChIP procedure.  
We have analyzed the immunoprecipitated products by a whole-genome approach, and we 
have validated the method by comparing the H3K9Ac profile at the SmRHO locus by both 
ChIP-qPCR and ChIP-Seq. It is evident from our results that H3K9 acetylation is high in the 
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5’ region of the SmRho gene in those developmental stages in which SmRho is expressed. The 
level of acetylation corresponds to the level of transcription. In contrast, in the body of the 
gene, H3K9 acetylation is relatively low. These findings are fully compatible to what is 
known from the literature. Our results indicate also that, while in the majority of sites qPCR 
and ChIP-Seq confirm each other, and despite the fact that both methods deliver the above 
outlined 5’-3’ profile, in some sites qPCR and ChIP-Seq enrichment factors can be different. 
We believe that this is due to the fact that bioinformatics analysis of ChIP-Seq data is still in 
its infancy and that artifacts are probably introduced by the data treatment. Fortunately, many 
laboratories have initiated the development of new or improved software tools [40] [41] . We 
intend to re-analyze our data when mature solutions become available. Nevertheless, we 
underline that by the very nature of the ChIP-Seq procedure (2 consecutive PCR, data 
treatment) for the moment the method should be considered explorative, and its results should 
always be confirmed by qPCR. Nevertheless, to our knowledge this is the first time that the 
ChIP-Seq technology has been applied to study protein-DNA interactions in a parasite.  
Work by others has clearly demonstrated the influence of histone modifying enzymes on the 
control of gene expression in S. mansoni [6] [10]. Our work shows that S. mansoni chromatin 
states can be analyzed by ChIP using antibodies that recognize known euchromatic and 
heterochromatic marks. It will now be possible to investigate if different chromatin states are 
responsible for gene expression regulation during adaptation of the parasite to different 
environments, maturation from larval to adult stages, and sexual differentiation. 
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Legends:  
Supplementary Figure 1: Antibody titration for N-ChIP analysis on S. mansoni 
N-ChIP analysis was performed with 1500 sporocysts and with increasing amounts of 
antibody that recognize H3K9Ac (Upstate) (A), H3K9Me3 (Abcam) (B), H3K27Me1 
(Upstate) (C) and H3K9Me3 (Upstate) (D). Immunoprecipitated DNA was quantified by 
qPCR of a region in body of the -tubulin gene. Input Recovery as % of input (%IR, y axis) is 
shown for each tested antibody (in µl or µg, x axis). The value % IR background indicates % 
IR without antibodies. On the right side of each graph, the corresponding western blot is 
shown. For anti H3 (Abcam) no ChIP experiments were performed (E). 
 
Figure 1: Stage specific expression of rhodopsin 
Ratios of transcript levels corresponding to SmRHO at different developmental stages of S. 
mansoni. Ratios were determined using real-time quantitative PCR and are expressed relative 
to mRNA -tubulin expression levels. Each histogram represents the average value of 
duplicates ± S.D. 
 
Figure 2: Schematic representation of the rhodopsin coding sequence on S.mansoni 
scaffold 001984 and enrichment of acetylated H3K9 along the gene 
Above: Seven exons were identified and are represented as gray boxes. The dashed box 
represents a 146 bp sequence that is present in the previously described rhodopsin sequence 
(Hoffman et al. 2001; AF155134) but that is absent in the Smp_scaff001984. Intron sizes are 
indicated and the position of each exon on the Smp_scaff001984. Primer sets R1 to R8 are 
shown (see supplementary table 1 for starting positions). Primers set R7 was used for 
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determination of the transcription level and spans exon 6 to 7, all other primers sets are for 
qPCR of immunoprecipitated DNA.  
Below: Chromatin immunoprecipitation was performed with antibodies against H3K9Ac on 
chromatin extracted from adults, miracidia, and cercariae. Immunoprecipitated DNA was 
analyzed by high throughput sequencing analysis on an Illumina/Solexa 1G analyzer (full 
line) or by qPCR (dotted line). For high throughput sequencing analysis, U0, U1 and U2 peak 
values for the regions corresponding to each amplicon (R1 to R8) were summed and 
normalized to the amplicon size. qPCR was performed with primer sets R1 to R8, the percent 
input recovery of each target sequence was normalized with the recovery of -tubulin. qPCR 
results are the average of three independent experiments. All data were normalized to the R1 
region. Connecting lines do not represent experimental data but are there to guide the eye. 
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